Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Endocrinologia Japonica
|
February 1, 1979
Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases
H Kajinuma, Y Kanazawa, H Sando, et al.
Diabetes
|
December 1, 1978
Comparison of the early time courses of the release of insulin that follow injections of tetragastrin, tolbutamide, xylitol, and glucose into the pancreatic artery of dogs
T Kuzuya, H Kajinuma, H Sando, et al.
Diabetes Care
|
March 1, 1979
Prevalence of major vascular complications at the initial visit among Japanese diabetic patients
E Miki, Y Akanuma, Y Kanazawa, et al.
Acta Diabetologica Latina
|
October 1, 1979
The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin
S Kawazu, Y Kanazawa, E Miki, et al.
Annals of the New York Academy of Sciences
|
January 1, 1990
Specificity in metabolic effects of cachectin/TNF and other related cytokines
M Kawakami, N Watanabe, H Ogawa, et al.
Diabetes Research and Clinical Practice
|
September 1, 1986
Serum gliclazide concentration in diabetic patients. Relationship between gliclazide dose and serum concentration
T Shiba, H Kajinuma, K Suzuki, et al.
Diabetes
|
February 1, 1987
Initial phase II clinical studies on midaglizole (DG-5128). A new hypoglycemic agent
S Kawazu, M Suzuki, K Negishi, et al.
Journal of Cellular Physiology
|
January 1, 1989
Cachectin/TNF kills or inhibits the differentiation of 3T3-L1 cells according to developmental stage
M Kawakami, N Watanabe, H Ogawa, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Endocrinologia Japonica
|
February 1, 1979
Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases
H Kajinuma, Y Kanazawa, H Sando, et al.
Diabetes
|
December 1, 1978
Comparison of the early time courses of the release of insulin that follow injections of tetragastrin, tolbutamide, xylitol, and glucose into the pancreatic artery of dogs
T Kuzuya, H Kajinuma, H Sando, et al.
Diabetes Care
|
March 1, 1979
Prevalence of major vascular complications at the initial visit among Japanese diabetic patients
E Miki, Y Akanuma, Y Kanazawa, et al.
Acta Diabetologica Latina
|
October 1, 1979
The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin
S Kawazu, Y Kanazawa, E Miki, et al.
Annals of the New York Academy of Sciences
|
January 1, 1990
Specificity in metabolic effects of cachectin/TNF and other related cytokines
M Kawakami, N Watanabe, H Ogawa, et al.
Diabetes Research and Clinical Practice
|
September 1, 1986
Serum gliclazide concentration in diabetic patients. Relationship between gliclazide dose and serum concentration
T Shiba, H Kajinuma, K Suzuki, et al.
Diabetes
|
February 1, 1987
Initial phase II clinical studies on midaglizole (DG-5128). A new hypoglycemic agent
S Kawazu, M Suzuki, K Negishi, et al.
Journal of Cellular Physiology
|
January 1, 1989
Cachectin/TNF kills or inhibits the differentiation of 3T3-L1 cells according to developmental stage
M Kawakami, N Watanabe, H Ogawa, et al.
Page
of 2